178 filings
Page 5 of 9
6-K
oqjyawhr40th0n9gk
7 Oct 16
Update from Alcobra on Recent FDA Communications
12:00am
6-K
voobo6c67tnoaymkl
29 Sep 16
Alcobra Announces IND Clinical Hold Affecting the MDX Phase III MEASURE Study
12:00am
6-K
fppfvaz9
30 Aug 16
Current report (foreign)
12:00am
6-K
2283y0
19 Jul 16
Alcobra Granted European Orphan Drug Designation for Metadoxine in Fragile X Syndrome
12:00am
6-K
9xtpc
19 Jul 16
Current report (foreign)
12:00am
6-K
jjresmqhsqj
8 Jun 16
Notice of Annual General Meeting of Shareholders
12:00am
6-K
bs1tkde914fo
18 May 16
Alcobra Announces First Quarter 2016 Financial Results and Provides Corporate Update
12:00am
EFFECT
jvznn yb2143
18 Mar 16
Notice of effectiveness
12:00am
CORRESP
l3vwlhu4blo jmuy
16 Mar 16
Correspondence with SEC
12:00am
UPLOAD
ttnj1aqf yiae73uhl
15 Mar 16
Letter from SEC
12:00am
F-3
au46churx4
4 Mar 16
Shelf registration (foreign)
12:00am
S-8
7v124tq
4 Mar 16
Registration of securities for employees
12:00am
6-K
t6emu1zo73
17 Feb 16
Alcobra Announces Fourth Quarter and Fiscal 2015 Financial Results and Provides Corporate Update
12:00am
424B5
34d5i
16 Nov 15
Prospectus supplement for primary offering
12:00am
6-K
7gt98qq
13 Nov 15
Alcobra Ltd. Prices Public Offering of Ordinary Shares
12:00am
6-K
f9u27j5w7ct hht0l2
12 Nov 15
Alcobra Announces Third Quarter 2015 Financial Results and Provides Corporate Update
12:00am
424B5
ebewv9t23ab9 xbo7n
12 Nov 15
Prospectus supplement for primary offering
12:00am
6-K
srbchp9
12 Nov 15
Report of Foreign Private Issuer
12:00am
6-K
mqcrzjnu7 0i3d
21 Sep 15
Current report (foreign)
12:00am